The Asia Pacific Enteric Disease Testing Market should witness market growth of 4.0% CAGR during the forecast period (2023-2029).
The enteric disease testing market is expected to experience growth over the forecast period. This is primarily attributed to the significant incidence of cholera. Therefore, it is anticipated that there will be a surge in demand for disease diagnostics due to an outbreak of enteric disease. Additionally, the market is expected to experience growth due to heightened government efforts to promote public awareness regarding proper hygiene, sanitation, and enteric infections.
The susceptibility to enteric infections is highest among newborns, young children, the elderly, and individuals with disabilities due to their weakened immune systems. Early recognition of these disorders is crucial to mitigate potential consequences. The method of diagnosis for enteric diseases was previously reliant on traditional methods, which necessitated skilled personnel and was a time-intensive process, leading to elevated mortality rates. The increasing demand for enteric disease testing is driven by the cost-efficiency of modern diagnostic systems coupled with the aforementioned considerations.
South Asia has made significant strides in enhancing the accessibility of sanitation facilities. As a result, there has been a significant improvement in the proportion of individuals with access to improved sanitation. The percentage of people with accessibility to better sanitation increased to 48% in 2015. Furthermore, the proportion of individuals who practice open defecation has decreased from 65% to 34%. In 2014, the Indian government initiated the Swacch Bharat Mission to attain universal sanitation coverage by 2019. The program has implemented a strategy to increase public knowledge of the importance of enhanced sanitation and access to safe water. Therefore, the regional market will experience significant growth in the coming years.
The China market dominated the Asia Pacific Enteric Disease Testing Market by Country 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $343.6 million by 2029. The Japan market is estimated to grow a CAGR of 3.4% during (2023-2029). Additionally, The India market would experience a CAGR of 4.7% during (2023-2029).
Based on End-user, the market is segmented into Hospital Laboratories, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. Based on Disease Type, the market is segmented into Bacterial, Viral and Parasitic. Based on Product Type, the market is segmented into Reagents & Consumables and Equipment. Based on Technique, the market is segmented into Immunodiagnostics and Molecular Diagnostics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Merck KGaA, Thermo Fisher Scientific, Inc., SGS S.A., Eurofins Scientific SE, Bureau Veritas S.A., Intertek Group PLC, TÜV Nord Group, PerkinElmer, Inc., Becton, Dickinson and Company and Neogen Corporation.
The enteric disease testing market is expected to experience growth over the forecast period. This is primarily attributed to the significant incidence of cholera. Therefore, it is anticipated that there will be a surge in demand for disease diagnostics due to an outbreak of enteric disease. Additionally, the market is expected to experience growth due to heightened government efforts to promote public awareness regarding proper hygiene, sanitation, and enteric infections.
The susceptibility to enteric infections is highest among newborns, young children, the elderly, and individuals with disabilities due to their weakened immune systems. Early recognition of these disorders is crucial to mitigate potential consequences. The method of diagnosis for enteric diseases was previously reliant on traditional methods, which necessitated skilled personnel and was a time-intensive process, leading to elevated mortality rates. The increasing demand for enteric disease testing is driven by the cost-efficiency of modern diagnostic systems coupled with the aforementioned considerations.
South Asia has made significant strides in enhancing the accessibility of sanitation facilities. As a result, there has been a significant improvement in the proportion of individuals with access to improved sanitation. The percentage of people with accessibility to better sanitation increased to 48% in 2015. Furthermore, the proportion of individuals who practice open defecation has decreased from 65% to 34%. In 2014, the Indian government initiated the Swacch Bharat Mission to attain universal sanitation coverage by 2019. The program has implemented a strategy to increase public knowledge of the importance of enhanced sanitation and access to safe water. Therefore, the regional market will experience significant growth in the coming years.
The China market dominated the Asia Pacific Enteric Disease Testing Market by Country 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $343.6 million by 2029. The Japan market is estimated to grow a CAGR of 3.4% during (2023-2029). Additionally, The India market would experience a CAGR of 4.7% during (2023-2029).
Based on End-user, the market is segmented into Hospital Laboratories, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. Based on Disease Type, the market is segmented into Bacterial, Viral and Parasitic. Based on Product Type, the market is segmented into Reagents & Consumables and Equipment. Based on Technique, the market is segmented into Immunodiagnostics and Molecular Diagnostics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Merck KGaA, Thermo Fisher Scientific, Inc., SGS S.A., Eurofins Scientific SE, Bureau Veritas S.A., Intertek Group PLC, TÜV Nord Group, PerkinElmer, Inc., Becton, Dickinson and Company and Neogen Corporation.
Scope of the Study
By End-user
- Hospital Laboratories
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
By Disease Type
- Bacterial
- Viral
- Parasitic
By Product Type
- Reagents & Consumables
- Equipment
By Technique
- Immunodiagnostics
- Molecular Diagnostics
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- SGS S.A.
- Eurofins Scientific SE
- Bureau Veritas S.A.
- Intertek Group PLC
- TÜV Nord Group
- PerkinElmer, Inc.
- Becton, Dickinson and Company
- Neogen Corporation
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Asia Pacific Enteric Disease Testing Market by End User
Chapter 5. Asia Pacific Enteric Disease Testing Market by Disease Type
Chapter 6. Asia Pacific Enteric Disease Testing Market by Product Type
Chapter 7. Asia Pacific Enteric Disease Testing Market by Technique
Chapter 8. Asia Pacific Enteric Disease Testing Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- SGS S.A.
- Eurofins Scientific SE
- Bureau Veritas S.A.
- Intertek Group PLC
- TÜV Nord Group
- PerkinElmer, Inc.
- Becton, Dickinson and Company
- Neogen Corporation
Methodology
LOADING...
